Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of 907.69 million as of January 23, 2025. Its market cap has decreased by -25.87% in one year.

Market Cap

907.69M

Enterprise Value

942.77M

Revenue

614.49M

Ranking

n/a

PE Ratio

n/a

Stock Price

12.65

Market Cap Chart

Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 907.69M, an increase of 720.69%. That is a compound annual growth rate of 7.44%.

Market Cap History

Date	Market Cap	% Change
Jan 22, 2025	907.69M	-8.95%
Dec 31, 2024	996.94M	-25.18%
Dec 29, 2023	1.33B	36.53%
Dec 30, 2022	975.86M	-40.05%
Dec 31, 2021	1.63B	49.42%
Dec 31, 2020	1.09B	-28.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	171.18B
GSK plc	55.31B
Haleon	33.62B
Smith & Nephew	8.96B
ConvaTec Group	4.93B
Hikma Pharmaceuticals	4.72B
HUTCHMED (China)	1.99B
Oxford Nanopore Technologies	1.44B

Market Cap Rankings